title: Successful Management of Elizabethkingia meningoseptica Meningitis with Intraventricular Vancomycin.
abstract: Elizabethkingia meningoseptica, formerly Chryseobacterium meningosepticum usually causes neonatal meningitis and is a rare cause of nosocomial meningitis in adults. E. meningoseptica is resistant to most antibiotics, and the use of inactive drugs as empirical therapy may contribute to poor outcome in many patients. Vancomycin, alone or in combination with rifampicin, has been successful in the treatment of meningitis in infants1. We present a case of E. meningoseptica meningitis in an adult who was treated initially with intravenous vancomycin and oral rifampicin, but did not respond to the treatment. Thereafter, intraventricular vancomycin was added which resulted in good treatment response.
authors.affiliation: Consultant, Infectious Disease.
authors.forename: Rajeev
authors.initials: R
authors.lastname: Soman
authors.affiliation: Resident.
authors.forename: Umang
authors.initials: U
authors.lastname: Agrawal
authors.affiliation: Fellow, FNB (Infectious Disease).
authors.forename: Mitesh
authors.initials: M
authors.lastname: Suthar
authors.affiliation: Consultant, Department of Neurosurgery.
authors.forename: Ketan
authors.initials: K
authors.lastname: Desai
authors.affiliation: Consultant, Department of Microbiology, PD Hinduja National Hospital and Medical Research Centre, Mumbai, Maharashtra.
authors.forename: Anjali
authors.initials: A
authors.lastname: Shetty
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D045247:Chryseobacterium; D045826:Flavobacteriaceae Infections / Q000188:drug therapy*; D006801:Humans; D057967:Infusions, Intraventricular; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy*; D012074:Remission Induction; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin